Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
482
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revolutionizing Stem Cell Sorting with Machine Learning: A Review of Trends, Tools, and Future Directions.

Iranian journal of medical sciences·2026
Same author

Levels of bone formation marker P1NP in individuals over 50 years: a systematic review and meta-analysis.

Journal of diabetes and metabolic disorders·2026
Same author

Measuring the Acceptance of Humanoid Robots in Adult Day Care Facilities.

Studies in health technology and informatics·2026
Same author

Impact of metformin on bone turnover markers: a systematic review and meta-analysis of clinical trials.

Archives of osteoporosis·2026
Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Related Experiment Video

Updated: Jan 8, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K

Technology and Dementia Preconference.

Arshia A Khan1, Patricia Khashayar2

  • 1University of Minnesota Duluth, Duluth, MN, USA.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 23, 2025
PubMed
Summary
This summary is machine-generated.

Robotic therapy improved mobility and cognition in dementia patients. This engaging approach increased physiological arousal, suggesting enhanced participation in physical activity for memory care residents.

More Related Videos

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

4.3K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.0K

Related Experiment Videos

Last Updated: Jan 8, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

4.3K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.0K

Area of Science:

  • Gerontology
  • Rehabilitation Science
  • Neuroscience

Background:

  • Dementia impacts over 55 million globally, causing declines in mobility, cognition, and daily function.
  • Structured physical activity can reduce cognitive decline by 30%, but apathy limits traditional therapy engagement.
  • Robotic-assisted therapy presents an interactive alternative for rehabilitation.

Purpose of the Study:

  • To investigate the impact of robotic-assisted therapy on mobility, cognition, and emotional well-being in memory care residents.
  • To assess the effectiveness of a robotic system in guiding physical therapy exercises.
  • To measure physiological and cognitive changes associated with robotic rehabilitation.

Main Methods:

  • A seven-week intervention involving seven memory care residents using a robotic system for guided physical therapy.
  • Electrodermal activity (EDA) was used to measure physiological responses and engagement.
  • Cognitive and functional status were assessed using the Brief Interview for Mental Status (BIMS) survey pre- and post-intervention.

Main Results:

  • Therapy sessions significantly increased mean EDA tonic values and standard deviation across all participants.
  • Higher EDA values indicated greater physiological arousal and engagement during robotic-assisted exercises.
  • Improvements in BIMS scores suggest cognitive benefits from the intervention.

Conclusions:

  • Robotic-assisted therapy is a promising non-pharmacological strategy for enhancing mobility, cognition, and emotional well-being in dementia care.
  • Increased EDA suggests heightened participant engagement, complementing cognitive improvements measured by BIMS.
  • Robotic rehabilitation can serve as a valuable adjunct to traditional therapies, improving quality of life for memory care residents.